Valuation: Ipca Laboratories Limited

Market Cap 444B 4.65B 4.03B 3.76B 3.44B 6.48B 6.58B 44.13B 17.32B 222B 17.46B 17.08B 739B P/E 2027 *
31.8x
P/E 2028 * 26.6x
Enterprise Value 432B 4.53B 3.92B 3.66B 3.35B 6.31B 6.41B 42.96B 16.86B 216B 17B 16.63B 719B EV / Sales 2027 *
4.01x
EV / Sales 2028 * 3.5x
Free-Float
54.94%
Yield 2027 *
0.33%
Yield 2028 * 0.36%
1 day+3.74%
1 week+1.51%
Current month+0.12%
1 month-2.14%
3 months+12.73%
6 months+22.64%
Current year+22.84%
1 week 1,671.65
Extreme 1671.65
1,783.8
1 month 1,645.9
Extreme 1645.9
1,941.4
Current year 1,392
Extreme 1392
1,941.4
1 year 1,252.95
Extreme 1252.95
1,941.4
3 years 849.25
Extreme 849.25
1,941.4
5 years 670
Extreme 670
1,941.4
10 years 200
Extreme 200
1,941.4
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Change 5-day change 1-year change 3-year change Capi.($)
+3.74%+1.51% - - 4.48B
-0.72%+9.63%+92.55%+131.52% 1,098B
-1.01%+1.67%+49.11%+49.09% 631B
+0.14%+1.91%+25.08%+63.26% 438B
-1.07%+3.44%+50.22%+39.54% 368B
-0.78%+1.00%+31.06%+38.62% 298B
-0.95%+1.07%+7.52%+7.58% 251B
-0.67%+6.18%+45.26%+57.75% 226B
+0.34%-0.29%-4.93%-50.58% 209B
+1.32%+0.03%+12.31%+69.12% 165B
Average +0.08%+1,657.21%+34.24%+45.10% 409.37B
Weighted average by Cap. -0.51%+1,331.50%+50.06%+66.48%

Financials

2027 *2028 *
Net sales 108B 1.13B 977M 914M 835M 1.57B 1.6B 10.71B 4.2B 53.87B 4.24B 4.15B 179B 120B 1.26B 1.09B 1.02B 931M 1.75B 1.78B 11.95B 4.69B 60.07B 4.73B 4.62B 200B
Net income 14B 147M 127M 119M 109M 205M 208M 1.39B 547M 7B 551M 539M 23.33B 16.7B 175M 152M 142M 129M 244M 248M 1.66B 652M 8.35B 657M 643M 27.82B
Net Debt -11.82B -124M -107M -100M -91.68M -173M -175M -1.18B -462M -5.92B -466M -455M -19.7B -23.66B -248M -215M -201M -183M -346M -351M -2.35B -924M -11.84B -932M -911M -39.42B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-08-11 1,749.30 +3.74% 23,911
26-08-10 ₹1,686.20 -2.92% 20,050
26-08-07 ₹1,736.85 +0.20% 5,314
26-08-06 ₹1,733.45 -1.89% 13,966
26-08-05 ₹1,766.85 +5.03% 11,991
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,748.40INR
Average target price
1,733.50INR
Spread / Average Target
-0.85%

Quarterly revenue - Rate of surprise